Other

Kunshan Xinyunda Biotech Co., Ltd.

Ningxia Wang

Yi Shan Jiang

Wu Chen

Xiaohua Lu

Yan Liu

Xiaoming Li

Yongbao Li

Xiujuan Ding

Xuzhao Du

Yongsheng Jin

Fang Lao

Lin Tan

Fangxing Ouyang

Hua Zhou

Baigang Wen

Junting Sun

Shang Ju

Tianyi Ke

Caijuan Jin

Dongxue Cui

Jiangen Qian

Xi Chong

Qiaoyun Zhou

Yihao Zhu

Yiming Yao

Disclosed are a composition containing 7-ethyl-10-hydroxycamptothecin, and a preparation method therefor and the use thereof. The composition contains SN-38, a lipid, albumin and Span 20.

Composition containing antitumor drug, and preparation method thereof and use thereof

Provided is a low-molecular-weight holothurian glycosarninoglycan, with the constituent units thereof being a glucuronic acid group, an N-acetaminogalactose group and a fucose group, and a sulfate ester group or acetyl ester group thereof. Glucuronic acid and N-acetaminogalactose are interconnected via &#x3b2;(1-3) and &#x3b2;(1-4) glucosidic bonds to form a backbone of a disaccharide repeating structural unit, and a fucose group is connected to the backbone as a side chain. On a molar ratio basis, the ratio of the glucuronic acid group:the N-acetaminogalactose group:the fucose group is 1:(0.8-1.2):(0.6-1.2). In the structure of the low-molecular-weight holothurian glycosaminoglycan, 10-30% of glucuronic acid groups are modified, on the 2-position, with a sulfate ester group, and the rest are hydroxyl groups; and a proportion of 10-30% of fucose groups is modified, on the 2-position, with an acetyl ester group, and the rest are hydroxyl or sulfate ester groups. The low-molecular-weight holothurian glycosarninoglycan of the present invention has anti-inflammation, anti-vasculopathy, anti-tumor or anti-tumor-metastasis functions, and the effect of improving learning and memory abilities, and can be used for preparing a related drug or health-care product.

Low-molecular-weight holothurian glycosaminoglycan and use thereof

Growing community of inventors

Jiangsu, China

Ningxia Wang